Your browser doesn't support javascript.
loading
Suppression of tumor angiogenesis by targeting the protein neddylation pathway.
Yao, W-T; Wu, J-F; Yu, G-Y; Wang, R; Wang, K; Li, L-H; Chen, P; Jiang, Y-N; Cheng, H; Lee, H W; Yu, J; Qi, H; Yu, X-J; Wang, P; Chu, Y-W; Yang, M; Hua, Z-C; Ying, H-Q; Hoffman, R M; Jeong, L S; Jia, L-J.
Afiliación
  • Yao WT; 1] Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China [3]
  • Wu JF; 1] Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Yu GY; 1] Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Wang R; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
  • Wang K; State Key Laboratory of Pharmaceutical Biotechnology, Department of Biochemistry, Nanjing University, Nanjing, China.
  • Li LH; Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Chen P; Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Jiang YN; 1] Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Cheng H; Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Lee HW; College of Pharmacy, Seoul National University, Seoul, Korea.
  • Yu J; College of Pharmacy, Seoul National University, Seoul, Korea.
  • Qi H; AntiCancer Biotech Beijing Co. Ltd, Beijing, China.
  • Yu XJ; Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wang P; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
  • Chu YW; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Yang M; AntiCancer Biotech Beijing Co. Ltd, Beijing, China.
  • Hua ZC; State Key Laboratory of Pharmaceutical Biotechnology, Department of Biochemistry, Nanjing University, Nanjing, China.
  • Ying HQ; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hoffman RM; 1] Department of Surgery, University of California, San Diego, CA, USA [2] AntiCancer, Inc., San Diego, CA, USA.
  • Jeong LS; College of Pharmacy, Seoul National University, Seoul, Korea.
  • Jia LJ; 1] Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Cell Death Dis ; 5: e1059, 2014 Feb 13.
Article en En | MEDLINE | ID: mdl-24525735
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pirimidinas / Neovascularización Fisiológica / Inhibidores de la Angiogénesis / Ciclopentanos / Células Endoteliales / Enzimas Activadoras de Ubiquitina / Membrana Corioalantoides / Neovascularización Patológica Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Death Dis Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pirimidinas / Neovascularización Fisiológica / Inhibidores de la Angiogénesis / Ciclopentanos / Células Endoteliales / Enzimas Activadoras de Ubiquitina / Membrana Corioalantoides / Neovascularización Patológica Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Death Dis Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido